An increased risk for fractures: Another cause of frailty in HIV-infected subjects

Endocrine

Volumn 41, Issue 3, 2012, Pages 347-349

  Gazzaruso, Carmine ^a,b  

^a Vascular and Endocrine Metabolic Diseases Unit and the Centre for Applied Clinical Research (CeRCA) Clinical Institute Beato Matteo   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; BONE METABOLISM; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; FRACTURE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFE EXPECTANCY; LIPODYSTROPHY; LIVER CELL CARCINOMA; LIVER DISEASE; LUNG CANCER; LUNG DISEASE; MENOPAUSE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; OSTEOPOROSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SMOKING; STROKE; VERTEBRA FRACTURE;

EID: 84862648149     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9640-0     Document Type: Editorial

References (20)

1. A.D. Gutierrez, A. Balasubramanyam, Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine 41, 1-10 (2012)
2. F. Fedele, N. Bruno, M. Mancone, Cardiovascular risk factors and HIV disease. AIDS Rev. 13, 119-129 (2011)
3. A. Morris, M.P. George, K. Crothers, L. Huang, L. Lucht, C. Kessinger, E.C. Kleerup, HIV and chronic obstructive pulmonary disease: it is worse and why? Proc. Am. Thorac. Soc. 8, 320-325 (2011)
4. O. Falade-Nwulia, C.L. Thio, Liver disease, HIV and aging. Sex. Health 8, 512-520 (2011)
5. K. Sigel, R. Dubrov, M. Silvergerg, K. Crothers, S. Braithwaite, A. Justice, Cancer screening in patients infected with HIV. Curr. HIV/AIDS Rep. 8, 142-152 (2011)
6. C. Gazzaruso, R. Bruno, A. Garzaniti, S. Giordanetti, P. Fratino, P. Sacchi, G. Filice, Hypertension among HIV-patients: prevalence and relationships to insulin-resistance and metabolic syndrome. J. Hypertens. 21, 1377-1382 (2003)
7. C. Gazzaruso, P. Sacchi, A. Garzaniti, P. Fratino, R. Bruno, G. Filice, Prevalence of metabolic syndrome among HIV patients. Diabetes Care 25, 1253-1254 (2002)
8. R. Bruno, C. Gazzaruso, P. Sacchi, C. Zocchetti, S. Giordanetti, A. Garzaniti, V. Ciappina, E. Maffezzini, R. Maserati, G. Filice, High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk. J. Acquir. Immune Defic. Syndr. 31, 363-365 (2002) (Pubitemid 35278640)
9. B. Hasse, B. Ledergerber, H. Furrer, Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin. Infect. Dis. 53, 1130-1139 (2011)
10. C. Torti, G. Mazziotti, P.A. Soldini, E. Focà, R. Maroldi, D. Gotti, G. Carosi, A. Giustina, High prevalence of radiological vertebral fractures in HIV-infected males. Endocrine. (2011). doi: 10.1007/s12020-011- 9586-7
11. G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123, 877-884 (2010)
12. G.A. McComsey, P. Tebas, E. Shane et al., Bone disease in HIV infection: a practical review and recommendations for HIV Care Providers. Clin. Infect. Dis. 51, 937-946 (2010)
13. R.M. Campos, A. de Piano, P.L. da Silva, et al., The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine. (2012). doi:10.1007/s12020-012-9613-3
14. G. Mazziotti, M. Gola, A. Bianchi et al., Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40, 102-108 (2011)
15. G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58-69 (2012)
16. J. Compston, The use of combination therapy in the treatment of postmenopausal osteoporosis. Endocrine 41, 11-18 (2012)
17. J.A. Kanis, E.V. McCloskey, H. Johansson, O. Strom, F. Borgstrom, National Osteoporosis Guideline Group. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporosis Int. 19, 1395-1408 (2008)
18. N.O. Foundation, Clinician's guide to prevention and treatment of osteoporosis (National Osteoporosis Foundation, Washington, 2010)
19. S. Adami, F. Bertoldo, M.L. Brandi et al., Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo 61, 1-25 (2009)
20. E. Focà, D. Motta, M. Borderi et al., Prospective evaluation of bone markers, paratormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect. Dis. 12, 38 (2012)